CLARIANE SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.88 EUR | +18.69% |
|
+18.54% | -21.80% |
| Apr. 26 | CLARIANE : Reiterated outlook backed by a buoyant Q1 |  |
| Apr. 26 | Transcript : Clariane SE, Q1 2024 Sales/ Trading Statement Call, Apr 26, 2024 |
| Sales 2024 * | 5.29B 5.66B | Sales 2025 * | 5.58B 5.97B | Capitalization | 201M 215M |
|---|---|---|---|---|---|
| Net income 2024 * | -21M -22.45M | Net income 2025 * | 58M 62.01M | EV / Sales 2024 * | 1.13 x |
| Net Debt 2024 * | 5.77B 6.17B | Net Debt 2025 * | 4.66B 4.98B | EV / Sales 2025 * | 0.87 x |
| P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
3.92
x | Employees | 56,000 |
| Yield 2024 * |
18.1% | Yield 2025 * |
21.8% | Free-Float | 62.56% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clariane SE
More news
| 1 day | +18.69% | ||
| 1 week | +18.54% | ||
| Current month | +27.54% | ||
| 1 month | +30.65% | ||
| 3 months | -20.61% | ||
| 6 months | -49.35% | ||
| Current year | -21.80% |
1 week
1.58
1.88
1 month
1.511.90
Current year
1.322.68
1 year
1.328.05
3 years
1.3234.76
5 years
1.3245.66
10 years
1.3245.66
| Managers | Title | Age | Since |
|---|---|---|---|
Sophie Boissard
CEO | Chief Executive Officer | 53 | 16-01-25 |
| Director of Finance/CFO | - | 18-03-31 | |
| Chief Tech/Sci/R&D Officer | - | 20-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 47 | 21-01-10 | |
Catherine Soubie
BRD | Director/Board Member | 58 | 14-03-17 |
| Chairman | 72 | 16-06-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1.88 | +18.69% | 1,415,480 |
| 24-04-25 | 1.584 | -2.22% | 232,593 |
| 24-04-24 | 1.62 | -2.64% | 178,631 |
| 24-04-23 | 1.664 | +0.48% | 214,644 |
| 24-04-22 | 1.656 | +4.41% | 534,896 |
Real-time Euronext Paris, April 26, 2024 at 11:36 am EDT
More quotes
Clariane SE (formerly Korian) is the European No. 1 private operator of full-care facilities for dependent people. Net sales break down by geographic zone as follows:
- France (49.1%): at the end of 2022, operated 619 facilities (32,974 beds) broken into assisted-living facilities (medical assisted living facilities for the elderly, retirement homes, long-term care facilities and rest homes) and medical facilities (follow-up care and rehabilitation clinics and psychiatric clinics). In addition, the group operates 55 facilities (3,092 beds) in Spain and 11 facilities (727 beds) in the United Kingdom;
- Germany (23.9%): operated 239 facilities (27,392 beds);
- Belgium (14.7%): operated 117 facilities (12,991 beds). Furthermore, the group operates 49 facilities (1,458 beds) in the Netherlands;
- Italy (12.3%): operated 110 facilities (9,360 beds).
Calendar
2024-06-12
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
1.88
EUR
Average target price
3.825
EUR
Spread / Average Target
+103.46%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.80% | 214M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- CLARI Stock
